Biomerieux

bioMerieux, headquartered in France and operating within the Research and Development Services industry, reported a total of approximately 1.18 billion kg CO2e in emissions for 2024. This total is composed of approximately 22 million kg CO2e from Scope 1 emissions and approximately 34 million kg CO2e from Scope 2 (market-based) emissions. The vast majority of their footprint, approximately 1.13 billion kg CO2e, falls under Scope 3 emissions.

For the 2023 reporting year, bioMerieux's total emissions were approximately 1.19 billion kg CO2e. Scope 1 emissions accounted for approximately 23 million kg CO2e, and Scope 2 emissions (market-based) were approximately 38 million kg CO2e. Scope 3 emissions were approximately 1.12 billion kg CO2e.

In terms of climate commitments, bioMerieux has set ambitious reduction targets. They aim for a 63% reduction in Scope 1 and 2 emissions by 2034, using 2019 as the baseline year. Additionally, they have a near-term target to reduce direct greenhouse gas emissions (Scope 1) and those from energy purchases (Scope 2) by 50% by 2030, also compared to 2019 levels.

Further demonstrating their commitment, bioMerieux has aligned with Science Based Targets initiative (SBTi) goals. They commit to reducing absolute Scope 1 and 2 GHG emissions by 63% by 2034 from a 2019 base year. They also aim for a 90% reduction in Scope 1 and Scope 2 GHG emissions by 2050 from a 2019 base year, and a 90% reduction in absolute Scope 3 GHG emissions by 2050 from a 2023 base year. bioMerieux is working towards achieving net-zero greenhouse gas emissions across its entire value chain by 2050. Furthermore, they commit to ensuring that 67% of their suppliers, by emissions, have science-based targets by 2026.